Mayne Pharma Group Ltd at Jefferies Healthcare Conference Transcript
And from Mayne Pharma, we have Shawn O'Brien, CEO and President.
' -
Thanks, Jeff and the Jefferies team for giving this opportunity to present the Mayne Pharma story. This company has been in a significant transition for the last eight months. I'm Shawn Patrick O'Brien, CEO and Managing Director of Mayne Pharma, and I'm joined here today with our CFO, Aaron Gray. We are ASX listed company and hence, we are governed by ASX and the Corps' Act in Australia. So we report earnings on a half year basis. Our fiscal year starts on July 1. And so we've -- the numbers here that are reported are numbers that are from our half year that we reported in February of this year for the first half of fiscal year '23. And then we've had prescription and other data that's updated more recently as we've progressed in the second half of fiscal year '23.
This is our disclaimer. Please take time to read this as we report on Australian IFRS and not on a GAAP basis. I joined Mayne Pharma back in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
